Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2015   |   Volume: 4   |   Issue: 3   |   Page: 387-390     View issue

Plasmablastic lymphoma of the testis in a human immunodeficienecy virus patient - report of a rare entity


,
Abstract

Testicular lymphoma is the second most common extra nodal lymphomas. It is a highly lethal disease with a median survival of 1-2 years. In human immunodeficiency virus (HIV) patients, primary testicular lymphomas are estimated to comprise > 6% of testicular tumors, and they tend to occur in younger patients. Testicular lymphoma can occasionally be the initial manifestation of the disease in HIV patients.Plasmablastic lymphoma (PBL), which is considered as a variant of diffuse large B-cell lymphoma is a highly aggressive tumor with poor prognosis. PBL has a well-established association with HIV infection and occurs most commonly in the oral cavity. The presentation at extra nodal sites and absence of usual hematolymphoid markers makes its diagnosis more difficult. PBL of the testis as the primary lesion in HIV patients has not been reported so far. We report a case of PBL presenting as a primary testicular lesion in a HIV patient with a grave prognosis.

Cite this article
Vancouver
Sarma N, Srinivasulu M. Plasmablastic lymphoma of the testis in a human immunodeficienecy virus patient - report of a rare entity. Clin Cancer Investig J. 2015;4(3):387-90. https://doi.org/10.4103/2278-0513.151944
APA
Sarma, N., & Srinivasulu, M. (2015). Plasmablastic lymphoma of the testis in a human immunodeficienecy virus patient - report of a rare entity. Clinical Cancer Investigation Journal, 4(3), 387-390. https://doi.org/10.4103/2278-0513.151944

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513